1-4 of 4
David C. Blakey
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial

Debashis Sarker, Ruth Plummer, Tim Meyer, Mikael H. Sodergren, Bristi Basu, Cheng Ean Chee, Kai-Wen Huang, Daniel H. Palmer, Yuk Ting Ma, T.R. Jeff Evans, Duncan R.C. Spalding, Madhava Pai, Rohini Sharma, David J. Pinato, James Spicer, Sarah Hunter, Vineet Kwatra, Joanna P. Nicholls, David Collin, Robert Nutbrown, Helen Glenny, Sonia Fairbairn, Vikash Reebye, Jon Voutila, Stephanie Dorman, Pinelopi Andrikakou, Peter Lloyd, Steve Felstead, Jenni Vasara, Robert Habib, Chris Wood, Pal Saetrom, Hans E. Huber, David C. Blakey, John J. Rossi, Nagy Habib
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (15): 3936–3946.
https://doi.org/10.1158/1078-0432.CCR-20-0414
Published: 03 August 2020
View article titled, MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial
Open the PDF for MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial in another window
Includes: Supplementary data
Journal Articles

Sensitization of Tumor-Associated Endothelial Cell Apoptosis by the Novel Vascular-Targeting Agent ZD6126 in Combination with Cisplatin

Hisatsugu Goto, Seiji Yano, Yuka Matsumori, Hirohisa Ogawa, David C. Blakey, Saburo Sone
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (22): 7671–7676.
https://doi.org/10.1158/1078-0432.CCR-04-1171
Published: 29 November 2004
View article titled, Sensitization of Tumor-Associated Endothelial Cell Apoptosis by the Novel Vascular-Targeting Agent ZD6126 in Combination with Cisplatin
Open the PDF for Sensitization of Tumor-Associated Endothelial Cell Apoptosis by the Novel Vascular-Targeting Agent ZD6126 in Combination with Cisplatin in another window
Journal Articles

Magnetic Resonance Imaging Measurements of the Response of Murine and Human Tumors to the Vascular-Targeting Agent ZD6126

Jeffrey L. Evelhoch, Patricia M. LoRusso, Zhanquan He, Zachary DelProposto, Lisa Polin, Thomas H. Corbett, Peter Langmuir, Catherine Wheeler, Andrew Stone, Joanna Leadbetter, Anderson J. Ryan, David C. Blakey, John C. Waterton
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (11): 3650–3657.
https://doi.org/10.1158/1078-0432.CCR-03-0417
Published: 01 June 2004
View article titled, Magnetic Resonance Imaging Measurements of the Response of Murine and Human Tumors to the Vascular-Targeting Agent ZD6126
Open the PDF for Magnetic Resonance Imaging Measurements of the Response of Murine and Human Tumors to the Vascular-Targeting Agent ZD6126 in another window
Journal Articles

Antitumor Activity of the Novel Vascular Targeting Agent ZD6126 in a Panel of Tumor Models

David C. Blakey, F. Russell Westwood, Mike Walker, Gareth D. Hughes, Peter D. Davis, Sue E. Ashton, Anderson J. Ryan
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (6): 1974–1983.
Published: 01 June 2002
View article titled, Antitumor Activity of the Novel Vascular Targeting Agent ZD6126 in a Panel of Tumor Models
Open the PDF for Antitumor Activity of the Novel Vascular Targeting Agent ZD6126 in a Panel of Tumor Models in another window